Ascent Group, LLC Amgen Inc Transaction History

Ascent Group, LLC

$1.21 Billion
Q2 2024

A detailed history of Ascent Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ascent Group, LLC holds 10,949 shares of AMGN stock, worth $3.5 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

10,949

Previous 10,918 0.28%

Holding current value

$3.5 Million

Previous $3.1 Million 10.21%

% of portfolio

0.28%

Previous 0.28%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $8,145 - $9,898	31 Added 0.28%	10,949 $3.42 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $134,703 - $162,604	-501 Reduced 4.39%	10,918 $3.1 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $83,358 - $94,037	326 Added 2.94%	11,419 $3.29 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $919,423 - $1.14 Million	4,205 Added 61.05%	11,093 $2.98 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $457,680 - $541,198	-2,136 Reduced 23.67%	6,888 $1.53 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $70,220 - $85,587	311 Added 3.57%	9,024 $2.18 Million
Q4 2022 Feb 16, 2023	SELL	$229.03 - $291.01 $20,383 - $25,899	-89 Reduced 1.01%	8,713 $2.29 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $4.33 Million - $4.88 Million	-19,295 Reduced 68.67%	8,802 $2.38 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $547,705 - $609,500	2,374 Added 9.23%	28,097 $6.95 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $4.39 Million - $4.86 Million	20,038 Added 352.47%	25,723 $6.22 Million
Q4 2021 Mar 01, 2022	BUY	$198.88 - $227.6 $1.13 Million - $1.29 Million	5,685 New	5,685 $1.3 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account